High-density lipoprotein or cyclodextrin extraction of cholesterol from aggregated LDL reduces foam cell formation

Area of Science:

• Cardiovascular Biology
• Atherosclerosis Research
• Lipid Metabolism

Background:

• Low-density lipoprotein (LDL) aggregation and retention in the arterial wall initiate atherosclerosis.
• Macrophages engulf and degrade aggregated LDL (agLDL) via exophagy.
• High-density lipoprotein (HDL) is known to be atheroprotective, but its precise mechanisms remain unclear.

Purpose of the Study:

• To investigate the role of HDL in the exophagy of agLDL by macrophages.
• To elucidate the direct interaction between HDL and agLDL during macrophage-mediated lipid processing.

Main Methods:

• Characterization of macrophage interaction with agLDL.
• In vitro analysis of agLDL catabolism by macrophages.
• Assessment of HDL's ability to extract free cholesterol from agLDL.
• Evaluation of foam cell formation inhibition by HDL and cholesterol-balanced cyclodextrins.

Main Results:

• Macrophages form extracellular digestive compartments for agLDL.
• Macrophage catabolism of agLDL increases its free cholesterol content.
• HDL directly extracts free cholesterol from agLDL, reducing macrophage cholesterol uptake and foam cell formation.
• HDL extracts free cholesterol, but not cholesterol esters, from agLDL independently of cells.

Conclusions:

• HDL actively participates in agLDL catabolism by extracting free cholesterol.
• This cholesterol extraction by HDL directly inhibits foam cell formation.
• The findings provide a novel perspective on HDL's atheroprotective function in atherosclerosis.